Bone Healing and Failure - Engineered Bone: Tissue Engineering Intelligence Unit - page 56

29. Kimble RB, Bain S, Pacifici R. The functional block of TNF but not IL-6 prevents bone loss in
ovariectomized mice. J Bone Miner Res 1997; 12:935-941.
30. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner
Res 1996; 11:1043-1051.
31. Bertolini DR, Nedwin GE, Bringma TS et al. Stimulation of bone resorption and inhibition of
bone formation in vitro by human tumor necrosis factor. Nature 1986; 319:516-518.
32. Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: A novel secreted protein involved in
the regulation of bone density. Cell 1997; 89:309-319.
33. Bucay N, Sarosi I, Dunstan CR et al. Osteoprotegerin-deficient mice develop early onset osteoporosis
and arterial calcification. Genes Dev 1998; 12:1260-1268.
34. Lacey DL, Timms E, Tan HL et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast
differentiation and activation. Cell 1998; 93:165-176.
35. Hofbauer LC, Khosla S, Dunstan CR et al. The role of osteoprotegerin and osteoprotegerin ligand
in the paracrine regulation of bone resorption. J Bone Miner Res 2000; 15:2-11.
36. Takahashi N, Udagawa N, Suda T. A new member of the tumor necrosis factor ligand family,
ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys
Res Commun 1999; 256:449-455.
37. Khan SN, Bostrom MPG, Lane JM. Bone growth factors. Orthop Clin N Am 2000; 31(3):375-387.
38. Bostrom MPG, Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop 1998;
355S:S124-S131.
39. Reddi AH. Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop 1998;
355S:S66-S72.
40 Yoshimura Y, Nomura S, Kawasaki S et al. Colocalization of noggin and bone morphogenetic
protein-4 during fracture healing. J Bone Miner Res 2001; 16(5):876-884.
41. Jingushi S, Heydemann A, Kana SK et al. Acidic fibroblast growth factor (aFGF) injection stimu-
lates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. J Orthopes
Res 1990; 8:364-371.
42. Canalis E, Centrella M, McCarthy TL. Effects of basic fibroblast growth factor on bone formation
in vitro. J Clin Invest 1988; 81:1572-1577.
43. Rodan SB, Weolowski G, Thomas K et al. Growth stimulation of rat calvaria osteoblastic cells by
acidic fibroblast growth factor. Endocrinology 1987; 121:1917-1923.
44. Nakamura T, Hara Y, Tagawa M et al. Recombinant human basic fibroblast growth factor acceler-
ates fracture healing by enhancing callus remodeling in experimental dog tibial fractures. J Bone
Miner Res 1998; 13:942-949.
45. Kawaguchi H, Kurokawa T, Hanada K et al. Stimulation of fracture repair by recombinant human
basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 1994;
135:774-781.
46. Radomsky ML, Thompson AY, Spiro RC et al. Potential role of fibroblast growth factor in en-
hancement of fracture healing. Clin Orthop 1998; 355S:S283-S293.
47. Canalis E, Centrella M, McCarthy TL. Growth factors and regulation of bone remodeling. J Clin
Invest 1988; 81:277-281.
48. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-derived growth factor re-
ceptor. Biochem Biophys Acta 1998; 1378:F79-F113.
49. Andrew JG, Hoyland J, Freemont AJ et al. Platelet derived growth factor expression in normally
healing human fractures. Bone 1995; 16:455-460.
50. Shimokado K, Raines EW, Madtes DK et al. A significant part of macrophage derived growth
factor consists of at least two forms of PDGF. Cell 1985; 43:277-286.
51. Nash TJ, Howlett CR,Martin C et al. Effect of platelet-derived growth factor on tibial osteotomies
in rabbits. Bone 1994; 15:203-208.
52. Zhang A, Chen J, Jin D. Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone
resorption directly: The role of receptor beta. Biochem Biophys Res Commum 1998; 251:190-194.
53. Johnson EE, Urist MR, Finerman GA. Repair of segmental defects of the tibia with cancellous
bone grafts augmented with human bone morphogenetic protein: A preliminary report. Clin Orthop
1988; 236:249-257.
54. Johnson EE, Urist MR, Finerman GA. Bone morphogenetic protein augmentation grafting of re-
sistant femoral nonunions: A preliminary report. Clin Orthop 1988; 230:257-265.
55. Johnson EE, Urist MR, Finerman GA. Resistant nonunions and partial or complete segmental
defects of long bones: Treatment with implants of a composite of human bone morphogenetic
protein (BMP) and autolyzed, antigen-extracted, allogenic (AAA) bone. Clin Orthop 1992;
277:229-237.